3D Single-Breath Chemical Shift Imaging Hyperpolarized Xe-129 MRI of Healthy, CF, IPF, and COPD Subjects

3D Single-breath Chemical Shift Imaging (3D-SBCSI) is a hybrid MR-spectroscopic imaging modality that uses hyperpolarized xenon-129 gas (Xe-129) to differentiate lung diseases by probing functional characteristics. This study tests the efficacy of 3D-SBCSI in differentiating physiology among pulmona...

Full description

Bibliographic Details
Main Authors: Steven Guan, Nick Tustison, Kun Qing, Yun Michael Shim, John Mugler, Talissa Altes, Dana Albon, Deborah Froh, Borna Mehrad, James Patrie, Alan Ropp, Braden Miller, Jill Nehrbas, Jaime Mata
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Tomography
Subjects:
Online Access:https://www.mdpi.com/2379-139X/8/5/215
_version_ 1797469751619878912
author Steven Guan
Nick Tustison
Kun Qing
Yun Michael Shim
John Mugler
Talissa Altes
Dana Albon
Deborah Froh
Borna Mehrad
James Patrie
Alan Ropp
Braden Miller
Jill Nehrbas
Jaime Mata
author_facet Steven Guan
Nick Tustison
Kun Qing
Yun Michael Shim
John Mugler
Talissa Altes
Dana Albon
Deborah Froh
Borna Mehrad
James Patrie
Alan Ropp
Braden Miller
Jill Nehrbas
Jaime Mata
author_sort Steven Guan
collection DOAJ
description 3D Single-breath Chemical Shift Imaging (3D-SBCSI) is a hybrid MR-spectroscopic imaging modality that uses hyperpolarized xenon-129 gas (Xe-129) to differentiate lung diseases by probing functional characteristics. This study tests the efficacy of 3D-SBCSI in differentiating physiology among pulmonary diseases. A total of 45 subjects—16 healthy, 11 idiopathic pulmonary fibrosis (IPF), 13 cystic fibrosis (CF), and 5 chronic obstructive pulmonary disease (COPD)—were given 1/3 forced vital capacity (FVC) of hyperpolarized Xe-129, inhaled for a ~7 s MRI acquisition. Proton, Xe-129 ventilation, and 3D-SBCSI images were acquired with separate breath-holds using a radiofrequency chest coil tuned to Xe-129. The Xe-129 spectrum was analyzed in each lung voxel for ratios of spectroscopic peaks, chemical shifts, and T2* relaxation. CF and COPD subjects had significantly more ventilation defects than IPF and healthy subjects, which correlated with FEV1 predicted (R = −0.74). FEV1 predicted correlated well with RBC/Gas ratio (R = 0.67). COPD and IPF had significantly higher Tissue/RBC ratios than other subjects, longer RBC T2* relaxation times, and greater RBC chemical shifts. CF subjects had more ventilation defects than healthy subjects, elevated Tissue/RBC ratio, shorter Tissue T2* relaxation, and greater RBC chemical shift. 3D-SBCSI may be helpful in the detection and characterization of pulmonary disease, following treatment efficacy, and predicting disease outcomes.
first_indexed 2024-03-09T19:25:36Z
format Article
id doaj.art-248f344f6b8643a1995f95e0718dca1d
institution Directory Open Access Journal
issn 2379-1381
2379-139X
language English
last_indexed 2024-03-09T19:25:36Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Tomography
spelling doaj.art-248f344f6b8643a1995f95e0718dca1d2023-11-24T02:56:46ZengMDPI AGTomography2379-13812379-139X2022-10-01852574258710.3390/tomography80502153D Single-Breath Chemical Shift Imaging Hyperpolarized Xe-129 MRI of Healthy, CF, IPF, and COPD SubjectsSteven Guan0Nick Tustison1Kun Qing2Yun Michael Shim3John Mugler4Talissa Altes5Dana Albon6Deborah Froh7Borna Mehrad8James Patrie9Alan Ropp10Braden Miller11Jill Nehrbas12Jaime Mata13Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA 22903, USADepartment of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA 22903, USADepartment of Radiation Oncology, City of Hope, Duarte, CA 91010, USADepartment of Medicine, University of Virginia, Charlottesville, VA 22903, USADepartment of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA 22903, USADepartment of Medicine, University of Missouri, Columbia, MO 65211, USADepartment of Medicine, University of Virginia, Charlottesville, VA 22903, USADepartment of Medicine, University of Virginia, Charlottesville, VA 22903, USADepartment of Medicine, University of Florida, Gainesville, FL 32611, USADepartment of Public Health, University of Virginia, Charlottesville, VA 22903, USADepartment of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA 22903, USADepartment of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA 22903, USADepartment of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA 22903, USADepartment of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA 22903, USA3D Single-breath Chemical Shift Imaging (3D-SBCSI) is a hybrid MR-spectroscopic imaging modality that uses hyperpolarized xenon-129 gas (Xe-129) to differentiate lung diseases by probing functional characteristics. This study tests the efficacy of 3D-SBCSI in differentiating physiology among pulmonary diseases. A total of 45 subjects—16 healthy, 11 idiopathic pulmonary fibrosis (IPF), 13 cystic fibrosis (CF), and 5 chronic obstructive pulmonary disease (COPD)—were given 1/3 forced vital capacity (FVC) of hyperpolarized Xe-129, inhaled for a ~7 s MRI acquisition. Proton, Xe-129 ventilation, and 3D-SBCSI images were acquired with separate breath-holds using a radiofrequency chest coil tuned to Xe-129. The Xe-129 spectrum was analyzed in each lung voxel for ratios of spectroscopic peaks, chemical shifts, and T2* relaxation. CF and COPD subjects had significantly more ventilation defects than IPF and healthy subjects, which correlated with FEV1 predicted (R = −0.74). FEV1 predicted correlated well with RBC/Gas ratio (R = 0.67). COPD and IPF had significantly higher Tissue/RBC ratios than other subjects, longer RBC T2* relaxation times, and greater RBC chemical shifts. CF subjects had more ventilation defects than healthy subjects, elevated Tissue/RBC ratio, shorter Tissue T2* relaxation, and greater RBC chemical shift. 3D-SBCSI may be helpful in the detection and characterization of pulmonary disease, following treatment efficacy, and predicting disease outcomes.https://www.mdpi.com/2379-139X/8/5/215hyperpolarized xenon-129MRICOPDcystic fibrosisidiopathic pulmonary fibrosis
spellingShingle Steven Guan
Nick Tustison
Kun Qing
Yun Michael Shim
John Mugler
Talissa Altes
Dana Albon
Deborah Froh
Borna Mehrad
James Patrie
Alan Ropp
Braden Miller
Jill Nehrbas
Jaime Mata
3D Single-Breath Chemical Shift Imaging Hyperpolarized Xe-129 MRI of Healthy, CF, IPF, and COPD Subjects
Tomography
hyperpolarized xenon-129
MRI
COPD
cystic fibrosis
idiopathic pulmonary fibrosis
title 3D Single-Breath Chemical Shift Imaging Hyperpolarized Xe-129 MRI of Healthy, CF, IPF, and COPD Subjects
title_full 3D Single-Breath Chemical Shift Imaging Hyperpolarized Xe-129 MRI of Healthy, CF, IPF, and COPD Subjects
title_fullStr 3D Single-Breath Chemical Shift Imaging Hyperpolarized Xe-129 MRI of Healthy, CF, IPF, and COPD Subjects
title_full_unstemmed 3D Single-Breath Chemical Shift Imaging Hyperpolarized Xe-129 MRI of Healthy, CF, IPF, and COPD Subjects
title_short 3D Single-Breath Chemical Shift Imaging Hyperpolarized Xe-129 MRI of Healthy, CF, IPF, and COPD Subjects
title_sort 3d single breath chemical shift imaging hyperpolarized xe 129 mri of healthy cf ipf and copd subjects
topic hyperpolarized xenon-129
MRI
COPD
cystic fibrosis
idiopathic pulmonary fibrosis
url https://www.mdpi.com/2379-139X/8/5/215
work_keys_str_mv AT stevenguan 3dsinglebreathchemicalshiftimaginghyperpolarizedxe129mriofhealthycfipfandcopdsubjects
AT nicktustison 3dsinglebreathchemicalshiftimaginghyperpolarizedxe129mriofhealthycfipfandcopdsubjects
AT kunqing 3dsinglebreathchemicalshiftimaginghyperpolarizedxe129mriofhealthycfipfandcopdsubjects
AT yunmichaelshim 3dsinglebreathchemicalshiftimaginghyperpolarizedxe129mriofhealthycfipfandcopdsubjects
AT johnmugler 3dsinglebreathchemicalshiftimaginghyperpolarizedxe129mriofhealthycfipfandcopdsubjects
AT talissaaltes 3dsinglebreathchemicalshiftimaginghyperpolarizedxe129mriofhealthycfipfandcopdsubjects
AT danaalbon 3dsinglebreathchemicalshiftimaginghyperpolarizedxe129mriofhealthycfipfandcopdsubjects
AT deborahfroh 3dsinglebreathchemicalshiftimaginghyperpolarizedxe129mriofhealthycfipfandcopdsubjects
AT bornamehrad 3dsinglebreathchemicalshiftimaginghyperpolarizedxe129mriofhealthycfipfandcopdsubjects
AT jamespatrie 3dsinglebreathchemicalshiftimaginghyperpolarizedxe129mriofhealthycfipfandcopdsubjects
AT alanropp 3dsinglebreathchemicalshiftimaginghyperpolarizedxe129mriofhealthycfipfandcopdsubjects
AT bradenmiller 3dsinglebreathchemicalshiftimaginghyperpolarizedxe129mriofhealthycfipfandcopdsubjects
AT jillnehrbas 3dsinglebreathchemicalshiftimaginghyperpolarizedxe129mriofhealthycfipfandcopdsubjects
AT jaimemata 3dsinglebreathchemicalshiftimaginghyperpolarizedxe129mriofhealthycfipfandcopdsubjects